Search

TU Delft ditched the usual model of outlicensing or seeking venture capital backing when it was looking to commercialise a novel wastewater treatment technology.

In the past five years the state of Saxony in the former East Germany has made great strides in creating a biosciences sector – outstripping progress made by some of its counterparts in the more prosperous west of the country.

Dental implant company Neoss Ltd raised £5 million in its third funding round, enabling it to further develop the technology and expand its sales and marketing operations.

A pre-designed biomanufacturing facility with advance planning permission is the latest carrot devised by the Industrial Development Authority (IDA) Ireland in its efforts to attract international biopharmaceutical manufacturing projects.

The European Commission is reviving a push for a common patent policy by asking for input of ideas from industry and stakeholders - a move that would renew a fierce debate that has spanned more than three decades.

Researchers at the Advanced Technology Institute at the University of Surrey recently reported that they have shown and observed a phenomenon called negative differential resistance - holding out the prospect of a new generation of cheap and fast semiconductors.

Venture capitalists are once again funding nanotech start-ups, but their overall investment is small compared with government funding and corporate R&D spending, says to a new report.

The UK's stem cell community has reacted with collective dismay at the final confirmation that Hwang Woo-suk's claims to have generated patient-specific embryonic stem cell lines were fraudulent. Nuala Moran takes a look.

For some it was like a very bad Greek tragedy, for others a hoax more naive than the Piltdown man. But Hwang Wo-suk's fall from grace puts the UK on level terms with South Korea in the race to generate embryonic stem cells from cloned embryos.

In his first interview since taking up the job, Bruno van Pottelsberghe, the 37-year-old newly appointed chief economist at the European Patent Office, bemoans the failure to create a single EU-wide patent.